Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Oncology"
DOI: 10.1155/2018/3979527
Abstract: Background PLK1 overexpression is oncogenic and is associated with poor prognosis in various cancers. However, the current PLK1 inhibitors have achieved limited clinical successes. On the other hand, although immunotherapies are demonstrating efficacy in treating… read more here.
Keywords: cancer; tumor immunity; plk1 inhibition; inhibition immunotherapy ... See more keywords